Skip to main content
Log in

Renal denervation cost effective for resistant hypertension

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2016/2017 Australian dollars

Reference

  • Chowdhury EK, et al. Cost-effectiveness of renal denervation therapy for treatment resistant hypertension: a best case scenario. American Journal of Hypertension : 13 Jul 2018. Available from: URL: http://doi.org/10.1093/ajh/hpy108

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Renal denervation cost effective for resistant hypertension. PharmacoEcon Outcomes News 809, 32 (2018). https://doi.org/10.1007/s40274-018-5184-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5184-8

Navigation